ASHLEY ADAMS: Open Payments
NPI 1982258190 · GLENWOOD SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$399 in 19 payments from 10 companies in 2025. Trend: 2023 $624 · 2024 $737 · 2025 $399
Food & beverage: $399
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $70 |
| PFIZER INC. | 3 | $64 |
| UCB, Inc. | 2 | $57 |
| TG Therapeutics, Inc. | 2 | $39 |
| Eisai Inc. | 2 | $37 |
| Merz Pharmaceuticals, LLC | 2 | $33 |
| Otsuka America Pharmaceutical, Inc. | 1 | $31 |
| Lilly USA, LLC | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| ARGENX US, INC. | 1 | $19 |
Products named: QULIPTA, NURTEC ODT, Fintepla, BRIUMVI, Leqembi, Xeomin, REXULTI, KISUNLA.
Industry payments across CO — which companies pay providers there.
